Business
Cancer patients will benefit from the potential for faster diagnosis and better access to specialist opinions, following the go-live of a digital pathology solution across five NHS sites in Devon and Cornwall. Technical and...
Tempus: Paige’s strong foundation in pathology and AI is rooted in its proprietary dataset of almost 7 million digitized pathology slides that are clinically annotated CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a...
Lumea, the U.S. leader in primary clinical digital pathology, is proud to announce it has received four prestigious awards this fall, recognizing the company's rapid growth and transformative impact on cancer diagnostics. Lumea was named to the...
OREM, Utah--(BUSINESS WIRE)--Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced that its platform, Techcyte Fusion™ (research use only (RUO) in the US, CE-IVDD-marked in...
EVIDENT: Expanded product offering propels digital pathology from simply creating images to generating new insights for pathologists WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Evident announces a definitive agreement to acquire Pramana,...
The latest from the Proscia blog. Tom Gallo is Proscia’s Chief Financial Officer. Arun Ananth is the company’s Chief Commercial Officer. For years, AI-driven pathology has promised to deliver top- and bottom-line impact for diagnostic...
